Resources

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website summarizing lessons learned to guide cervical cancer prevention program planning in low-resource settings. It demonstrates that formative research is a necessary component of overall planning, discusses formative research issues specific to cervical cancer, and explains how research results may be used for strategic planning within the cervical cancer context.

This issue of Outlook reviews the evidence base for microfinance approaches to improve and address women’s health. It begins with background on the microfinance sector and links between microfinance and health. Interventions and approaches focused on family planning, women’s health services utilization and access (including health financing mechanisms), and HIV prevention are discussed. The issue concludes with suggested operational considerations for integration and priorities for future research. Some positive experiences with microfinance and women’s health signify that this area merits increased attention, yet more evidence of impact is needed.

This literature review details the key findings on the feasibility and acceptability of home delivery of depo-subQ provera 104™ in the Uniject™ injection system  (depo-subQ in Uniject). The review focused on self-injection and looked specifically at subcutaneous depot medroxyprogesterone acetate (DMPA) compared to the intramuscular formulation; considerations for home administration of injectable contraception, particularly in low-resource settings; and identified research needs for home administration, including self-injection, of depo-subQ in Uniject. A six-page briefing summary of this review is also available.

This Alliance for Cervical Cancer Prevention fact sheet summarizes evidence published since 2009 on cervical cancer screening approaches for low-resource settings.

This report assesses global readiness to fight cervical cancer using new approaches and new technologies, especially in regions where the disease is a common killer. It underscores the urgent need for the global community to prioritize cervical cancer prevention and control on global health and development agendas.